RESEARCH-USE BIOSIMILAR ANTIBODY
Bimagrumab
Monoclonal antibody · IgG1
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness.
TARGETACVR2B
YMonoclonal antibody
CATALOGSC-BS-710
CATALOG NUMBERSC-BS-710
MOLECULAR WEIGHTApprox. 142.78 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody that blocks activin type II receptor (ActRII), with KDs of 1.7 pM and 434 pM for human ActRIIB and ActRIIA, respectively. Bimagrumab can be used for the research of pathological muscle loss and weakness.
Bimagrumab is a recombinant research-use antibody directed against ACVR2B.